Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 31, Issue 3, 2000, Pages 264-269

  Marchand, Valerie ^a   Baker, Susan S ^a   Stark, Tracy J ^a   Baker, Robert D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Appetite stimulant; Growth; Nutrition

Indexed keywords

APPETITE STIMULANT; C PEPTIDE; GROWTH HORMONE; INSULIN; MEGESTROL ACETATE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ADOLESCENT; ADRENAL SUPPRESSION; ADULT; ARTICLE; CALORIC INTAKE; CHILD; CHILD GROWTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE INTOLERANCE; HORMONE BLOOD LEVEL; HUMAN; INFANT; LUNG FIBROSIS; LUNG FUNCTION; MALE; MALNUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

ADOLESCENT; ANTHROPOMETRY; BODY COMPOSITION; CACHEXIA; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; ENERGY INTAKE; FEMALE; GLUCOSE; HUMANS; INFANT; MALE; MEGESTROL ACETATE; NUTRITION DISORDERS; RESPIRATORY FUNCTION TESTS; WEIGHT GAIN;

EID: 0033858884     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200009000-00012     Document Type: Article

References (44)

1. The cystic fibrosis gene and resting energy expenditure
2. Energy expenditure of patients with cystic fibrosis
3. Increased energy expenditure in young children with cystic fibrosis
4. Cystic fibrosis and malnutrition
5. Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis
6. Complications of gastroesophageal reflux in patients with cystic fibrosis
7. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto
8. Nutritional rehabilitation in cystic fibrosis: A 5-year follow-up study
9. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis
10. Nutritional rehabilitation of malnourished patients with cystic fibrosis
11. Nutritional management of cystic fibrosis
12. Nutritional rehabilitation in cystic fibrosis: Controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease
13. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis
14. Short-term clinical, nutritional, and functional effects of continuous elemental enteral alimentation in children with cystic fibrosis
15. Short-term pulmonary effects of total parenteral nutrition in children with cystic fibrosis
16. Enteral-tube feeding as adjunct therapy in malnourished patients with cystic fibrosis: A clinical study and literature review
17. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis
18. Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: A controlled study, including effects of protein turnover
19. Nutritional status, growth and development in children undergoing intensive treatment for cystic fibrosis
20. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia
21. Appetite stimulation and weight gain with megestrol acetate
22. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer
23. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia
24. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia
25. Megestrol acetate in cancer cachexia
26. Prospective randomized trial of two dose levels of megestrol acetate in the management of anorexiacachexia syndrome in patients with metastatic cancer
27. Megestrol acetate in patients with AIDS and cachexia
28. Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia
29. Megestrol acetate in patients with AIDS-related cachexia
30. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection
31. Megestrol acetate for anorexia and cachexia
32. Megestrol acetate treatment of growth failure in children infected with human immunodeficiency virus
33. Megestrol acetate for treatment of anorexia associated with human immunodeficiency virus infection in children
34. Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumours
35. Body-composition changes in patients who gain weight while receiving megestrol acetate
36. Low-dose megestrol increases serum albumin in malnourished dialysis patients
37. Glucocorticoid-like activity of megestrol. A summary of Food and Drug Administration experience and a review of the literature
38. Megestrol-induced Cushing's syndrome
39. Induction of adrenal suppression by megestrol acetate in patients with AIDS
40. Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer
41. Genetic determination of diabetes mellitus in patients with cystic fibrosis
42. Glucose tolerance in patients with cystic fibrosis: Five-year prospective study
43. Insulin resistance and development of diabetes mellitus associated with megestrol acetate therapy
44. Hyperglycemia in an AIDS patient taking megestrol